We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.44B
AUM Growth
-$465M
Cap. Flow
-$442M
Cap. Flow %
-30.7%
Top 10 Hldgs %
11.9%
Holding
1,595
New
313
Increased
337
Reduced
470
Closed
413

Sector Composition

Rank Sector Weight
1 Technology 17.01%
2 Healthcare 10.93%
3 Consumer Discretionary 9.87%
4 Industrials 9.31%
5 Financials 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTA
451
DELISTED
Centessa Pharmaceuticals
CNTA
$622K 0.04%
68,900
-209
-0.3% -$1.98K
SWTX
452
DELISTED
SpringWorks Therapeutics
SWTX
$619K 0.04%
16,437
XLF icon
453
State Street Financial Select Sector SPDR ETF
XLF
$58.8B
$617K 0.04%
15,000
-10,000
-40% -$412K
NTST
454
NETSTREIT Corp
NTST
$2.1B
$615K 0.04%
+38,213
New +$657K
ONC
455
BeOne Medicines Ltd
ONC
$39.4B
$613K 0.04%
4,300
-2,700
-39% -$416K
SLB icon
456
CALL
SLB Ltd
SLB
$75B
$613K 0.04%
+13,000
New +$627K
IRON icon
457
Disc Medicine
IRON
$2.97B
$613K 0.04%
13,600
+10,100
+289% +$343K
ARE icon
458
Alexandria Real Estate Equities
ARE
$8.56B
$612K 0.04%
5,229
-3,235
-38% -$386K
S icon
459
SentinelOne
S
$7.34B
$610K 0.04%
29,000
+19,818
+216% +$407K
FHI icon
460
Federated Hermes
FHI
$4.72B
$609K 0.04%
18,531
+3,903
+27% +$131K
ARKO icon
461
ARKO Corp
ARKO
$635M
$608K 0.04%
+96,994
New +$521K
SFM icon
462
Sprouts Farmers Market
SFM
$8.01B
$603K 0.04%
7,204
-16,550
-70% -$1.21M
RMD icon
463
ResMed
RMD
$30.7B
$602K 0.04%
3,145
-5
-0.2% -$1.01K
ESPR
464
DELISTED
Esperion Therapeutics
ESPR
$601K 0.04%
270,889
+242,926
+869% +$571K
HPE icon
465
Hewlett Packard
HPE
$70.5B
$601K 0.04%
+28,396
New +$523K
XPRO icon
466
Expro Ltd
XPRO
$1.91B
$601K 0.04%
26,200
+9,064
+53% +$188K
WM icon
467
Waste Management
WM
$91B
$600K 0.04%
+2,812
New +$585K
JXN icon
468
Jackson Financial
JXN
$8.8B
$595K 0.04%
8,013
-6,295
-44% -$450K
LYV icon
469
Live Nation Entertainment
LYV
$42.1B
$593K 0.04%
6,322
-17,689
-74% -$1.67M
BBIO icon
470
BridgeBio Pharma
BBIO
$16.5B
$590K 0.04%
23,311
+11,797
+102% +$323K
AMAT icon
471
CALL
Applied Materials
AMAT
$428B
$590K 0.04%
2,500
-1,500
-38% -$322K
VFC icon
472
VF Corp
VFC
$5.89B
$590K 0.04%
43,696
-5,259
-11% -$69K
CBU icon
473
Community Bank
CBU
$3.41B
$589K 0.04%
12,486
-19,530
-61% -$883K
BP icon
474
BP
BP
$107B
$589K 0.04%
+16,326
New +$612K
NTAP icon
475
NetApp
NTAP
$37.2B
$588K 0.04%
4,569
-879
-16% -$98.7K

Similar funds

Prelude Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Prelude Capital Management held 1,595 positions worth $1.44B, down 24% from $1.91B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $442M in Q2 2024, closing 413 positions and reducing 470 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $16.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Constellation Energy worth $6.37M.

  • Prelude Capital Management's largest Q2 2024 buy was Constellation Energy: 31,786 shares worth $6.37M.
  • Prelude Capital Management added most to Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024, an estimated $6.05M increase.
  • Prelude Capital Management's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $13.1M.
  • Prelude Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $16.5M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $1.44B portfolio in Q2 2024.
  • Prelude Capital Management opened 313 new positions and closed 413 in Q2 2024.
  • Prelude Capital Management's portfolio value fell 24% quarter-over-quarter to $1.44B.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.